Alzheimer's drug shows positive results in early trial

The drug significantly improved memory and other factors in patients when compared to a placebo, and more details about the study will be released in November.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Washington ,United States ,Steven Senne ,Eli Lilly ,Graig Suvannavejh ,Japan Eisai Co ,Alzheimer Association ,Drug Administration ,Eisai Co ,Biogen Inc ,Mizuho Securities ,Massachusetts Based Biogen ,Indianapolis Based Eli Lilly ,